 1. Withdrawal criteria for the primary study with the exception of subjects who discontinued due to a dose reduction or status epilepticus. For subjects entering from EP0060, if the subject or legal guardian withdraws consent solely due to route of LCM administration iv or if the subject requires more than 10 iv LCM infusions, the subject may be allowed to participant in SP848 after discussion with and agreement from the Medical Monitor 